• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016 - Product Image

Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016

  • ID: 1194601
  • December 2009
  • 58 pages
  • GlobalData

Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016

Summary

Our “Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016” report is an essential source of information and analysis on the global Drug Eluting Stents (DES) market. The report identifies the key trends shaping and driving the dynamism in the global Drug Eluting Stents (DES) market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Drug Eluting Stents (DES) sector.

Scope

- Annualized global Drug Eluting Stents (DES) market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008.
- Analysis and review of the key events and milestones that will impact the future of the global Drug Eluting Stents (DES) market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these READ MORE >

Note: Product cover images may vary from those shown

1 Table Of Contents
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
3 Global DES Market : Market Characterization
3.1 Overview
3.2 DES, Revenue ($ m), Global, 2002 - 2009
3.3 DES, Revenue ($ m), Global, 2009 - 2016
3.4 DES: Market Dynamics
3.4.1 Market Drivers
3.4.1.1 Increasing Prevalence of Coronary Artery Disease to Drive DES Market
3.4.1.2 Rise in Obesity and Increasing Aging Population Worldwide to Advance the Market
3.4.1.3 Innovation to Drive the Market
3.4.1.4 Reduction in Re-Interventions in Diabetics- A Population Highly Susceptible To Restenosis to Boost Sales
3.4.1.5 High Reimbursement Coverage to Boost Adoption
3.4.1.6 Minimally Invasive Surgery to Play Vital Role in Market Development
3.4.2 Market Restraints
3.4.2.1 High Cost of DES to Hamper the Market Growth
3.4.2.2 Side effects like Late-stent Thrombosis and Requirement of Prolonged Dual Anti-platelet Therapy with DES Use to Affect Market Expansion
3.4.2.3 Negative Publicity Related to Stent Market Have Affected the Usage of DES
3.4.2.4 Alternative Treatment Options Creating a Threat to the Usage of Coronary Stents
3.5 DES: Perception Analysis
3.6 DES: Opportunities and Unmet Need
3.7 Key Takeaway
4 Global DES Market : Competitive Assessment
4.1 Overview
4.2 Strategic Competitive Assessment
4.3 Company Shares 2009
4.3.1 Cordis Corporation (Johnson & Johnson)
4.3.2 Boston Scientific
4.3.3 Medtronic
4.3.4 Abbott Laboratories
4.3.5 Others
4.4 Product Profiles of the Major Marketed Products in the DES Market
4.4.1 Cypher
4.4.1.1 Overview
4.4.1.2 Efficacy
4.4.1.3 Safety Profile
4.4.1.4 Pricing
4.4.1.5 Clinical Study Details
4.4.2 Taxus
4.4.2.1 Overview
4.4.2.2 Efficacy
4.4.2.3 Safety
4.4.2.4 Pricing
4.4.2.5 Clinical Study Details
4.4.3 Endeavor
4.4.3.1 Overview
4.4.3.2 Efficacy
4.4.3.3 Safety Profile
4.4.3.4 Pricing
4.4.3.5 Clinical Study Details
4.4.4 Xience/Promus
4.4.4.1 Overview
4.4.4.2 Efficacy
4.4.4.3 Safety Profile
4.4.4.4 Pricing
4.4.4.5 Clinical Study Details
4.5 Key Takeaway
5 Global DES Market: Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 DES - Pipeline by Clinical Phase of Development
5.4 Profiles of Promising Devices in Clinical Development
5.4.1 Endeavor Resolute
5.4.1.1 Overview
5.4.1.2 Efficacy
5.4.1.3 Safety
5.4.1.4 Clinical Study Details
5.4.2 VESTAsync
5.4.2.1 Overview
5.4.2.2 Efficacy
5.4.2.3 Safety
5.4.2.4 Clinical Study Details
5.4.3 Nobori Stent
5.4.3.1 Overview
5.4.3.2 Efficacy
5.4.3.3 Safety
5.4.3.4 Clinical Study Details
5.4.4 XIENCE NANO
5.4.4.1 Overview
5.4.4.2 Efficacy
5.4.4.3 Safety
5.4.4.4 Clinical Study Details
5.5 DES Market: List of Pipeline Products
5.6 Key Takeaway
6 Global DES Market : Implications for Future Market Competition
6.1 Strategic Competitor Assessment
7 Global DES Market: Emerging Companies
7.1 Introduction
8 Appendix
8.1 Definitions
8.1.1 Drug Eluting Stents (DES)
8.2 Research Methodology
8.3 Secondary Research
8.4 Primary Research
8.5 Models
8.6 Forecasts
8.7 Expert Panels
8.8 Consulting
8.9 Contact Us
8.10 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: DES, Revenue ($ m), Global, 2002 - 2009 10
Table 2: DES, Revenue ($ m), Global, 2009 - 2016 11
Table 3: Company Shares, US, 2009 22
Table 4: CYPHER Clinical Study Details - I 25
Table 5: CYPHER Clinical Study Details - II 25
Table 6: CYPHER Clinical Study Details - III 26
Table 7: Endeavor Clinical Study Details - I 29
Table 8: Endeavor Clinical Study Details - II 30
Table 9: Endeavor Clinical Study Details - III 30
Table 10: XIENCE Safety Data 31
Table 11: XIENCE Clinical Study Details - I 32
Table 12: XIENCE Clinical Study Details - II 32
Table 13: XIENCE Clinical Study Details - III 33
Table 14: XIENCE Clinical Study Details - IV 33
Table 15: XIENCE Clinical Study Details - V 34
Table 16: XIENCE Clinical Study Details - VI 34
Table 17: Endeavor Resolute Clinical Findings - I 41
Table 18: Endeavor Resolute Clinical Findings - II 42
Table 19: NOBORI Stent Clinical Trial Details 45
Table 20: DES Pipeline Product Summary - I 47
Table 21: DES Pipeline Product Summary - II 48
Table 22: DES Emerging Companies and Pipeline Products - I 52
Table 23: DES Emerging Companies and Pipeline Products - II 53

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos